Blue Bell Private Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.14K | Sell |
129
-27
| -17% | -$658 | ﹤0.01% | 610 |
|
2025
Q1 | $3.24K | Hold |
156
| – | – | ﹤0.01% | 604 |
|
2024
Q4 | $3.68K | Hold |
156
| – | – | ﹤0.01% | 568 |
|
2024
Q3 | $4K | Hold |
156
| – | – | ﹤0.01% | 587 |
|
2024
Q2 | $3.67K | Buy |
156
+40
| +34% | +$940 | ﹤0.01% | 596 |
|
2024
Q1 | $3.34K | Hold |
116
| – | – | ﹤0.01% | 605 |
|
2023
Q4 | $3.81K | Hold |
116
| – | – | ﹤0.01% | 582 |
|
2023
Q3 | $3.24K | Hold |
116
| – | – | ﹤0.01% | 538 |
|
2023
Q2 | $3.96K | Sell |
116
-75
| -39% | -$2.56K | ﹤0.01% | 527 |
|
2023
Q1 | $5.75K | Hold |
191
| – | – | ﹤0.01% | 447 |
|
2022
Q4 | $5.4K | Sell |
191
-1
| -0.5% | -$28 | ﹤0.01% | 452 |
|
2022
Q3 | $6K | Hold |
192
| – | – | ﹤0.01% | 428 |
|
2022
Q2 | $6K | Hold |
192
| – | – | ﹤0.01% | 461 |
|
2022
Q1 | $9K | Sell |
192
-25
| -12% | -$1.17K | ﹤0.01% | 418 |
|
2021
Q4 | $13K | Sell |
217
-85
| -28% | -$5.09K | ﹤0.01% | 353 |
|
2021
Q3 | $22K | Hold |
302
| – | – | 0.01% | 126 |
|
2021
Q2 | $28K | Buy |
+302
| New | +$28K | 0.01% | 125 |
|